Affiliation:
1. Chemical Biology Program, Memorial Sloan Kettering Cancer Center New York 10065 USA
2. Pharmacology Program of the Weill Cornell Graduate School of Medical Sciences Memorial Sloan Kettering Cancer Center New York 10065 USA
3. Tri-Institutional PhD Program in Chemical Biology Memorial Sloan Kettering Cancer Center New York 10065 USA
Abstract
AbstractSmall molecule inhibitors of the intracellular serine peptidases DPP8 and DPP9 (DPP8/9) activate the NLRP1 and CARD8 inflammasomes, but the key DPP8/9 substrates have not yet been identified. DPP8/9 cleave after proline to remove N‐terminal dipeptides from peptides or proteins, and studies using pseudo‐peptide reporter substrates have suggested that these enzymes may play key roles in the catabolism of many proline‐containing peptides generated by the proteasome. Here, we evaluated the degradation of a wide array of actual peptides in cell lysates, and discovered that DPP8/9 are not in fact involved in the processing of the vast majority of proline‐containing peptides. Overall, these results indicate that DPP8/9 have a much more limited substrate scope than previously thought, and likely specifically cleave some critically important, but as yet unknown, intracellular peptide or protein that regulates inflammasome activation.
Funder
National Institutes of Health